GAMMA Investing’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
GAMMA Investing's ELV Position: Q2 2026 in Review
GAMMA Investing increased its Elevance Health (ELV) stake by 61% in Q2 2026, buying an estimated $671K and bringing the position to 4,796 shares worth $1.85M. The position accounts for 0.07% of the portfolio, ranked #233.
GAMMA Investing first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- GAMMA Investing held 4,796 shares of Elevance Health worth $1.85M as of Q2 2026.
- GAMMA Investing bought 1,808 Elevance Health shares in Q2 2026, an estimated $671K.
- Elevance Health made up 0.07% of GAMMA Investing's portfolio in Q2 2026, its #233 holding.
- GAMMA Investing first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.